The Discounted Cash Flow (DCF) valuation of FibroGen Inc (FGEN) is (93.41) USD. With the latest stock price at 0.39 USD, the upside of FibroGen Inc based on DCF is -24052.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 9.5% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (654.14) - (51.60) | (93.41) |
| Upside | -167828.3% - -13329.9% | -24052.0% |